BDX Becton Dickinson
S&P 500 CompaniesDividend Aristocrats
Healthcare · Surgical & Medical Instruments & Apparatus
Becton Dickinson (BDX) is a healthcare company in the Surgical & Medical Instruments & Apparatus industry, with a market capitalization of $39.7 billion. Shares last traded at $143.96, 32.4% below their 52-week high. Over the past year the stock is down 15.3%. BDX trades at a price-to-earnings ratio of 23.64, below the Surgical & Medical Instruments & Apparatus median of 28.73. Net profit margin is 7.7%, above the peer median of -7.6%. Revenue grew 8.2% year over year. The shares yield 3.6% in dividends.
Performance
Chart
Full chart →Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.
Technicals
Financials
Latest reported annual period ending 2025-09-30 · SEC EDGAR/XBRL.
Recent earnings
| Period | EPS (diluted) | Reported |
|---|---|---|
| Q2 2026 | $0.25 | 2026-05-07 |
| Q1 2026 | $1.34 | 2026-02-09 |
| FY 2025 | $5.82 | 2025-11-25 |
| Q3 2025 | $4.10 | 2025-08-07 |
| Q2 2026 | $2.11 | 2026-05-07 |
| Q1 2026 | $1.04 | 2026-02-09 |
Surgical & Medical Instruments & Apparatus peers
BDX vs 14 industry peers (Surgical & Medical Instruments & Apparatus), by market cap.
| SYK | Stryker Corporation | $118.1B | 36.38 | 4.70 | 12.9% | +2.28% |
| MMM | 3M | $83.9B | 25.82 | 3.36 | 13.0% | +1.10% |
| BSX | Boston Scientific | $67.3B | 23.27 | 3.35 | 14.4% | +0.64% |
| BDX | Becton Dickinson | $39.7B | 23.64 | 1.82 | 7.7% | +1.62% |
| MDLN | Medline Inc. | $29.4B | — | — | — | -1.47% |
| DXCM | DexCom | $28.0B | 33.43 | 6.00 | 17.9% | +1.69% |
| RMD | ResMed | $27.4B | 19.53 | 5.32 | 27.2% | +1.24% |
| WST | West Pharmaceutical Services | $23.2B | 46.92 | 7.54 | 16.1% | +1.35% |
| SOLV | Solventum | $13.1B | — | — | — | +1.21% |
| PEN | Penumbra Inc | $12.5B | 70.18 | 8.88 | 12.7% | +0.28% |
| GMED | Globus Medical Inc | $10.8B | 19.99 | 3.66 | 18.3% | +5.00% |
| BAX | Baxter International | $10.3B | -10.74 | 0.91 | -8.5% | +2.58% |
| PODD | Insulet Corporation | $10.1B | 40.84 | 3.73 | 9.1% | +1.51% |
| GKOS | Glaukos Corp | $7.7B | -40.92 | 15.13 | -37.0% | +2.53% |
Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.